Patrick D. Walsh
Board Member
Ani Pharmaceuticals Inc (ANIP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Patrick D. Walsh
Patrick D. Walsh is recorded as Board Member and CEO at Ani Pharmaceuticals Inc (ANIP). Ani Pharmaceuticals Inc reported in an 8-K filed May 23, 2025 that Patrick D. Walsh was appointed director, effective May 22, 2025. Ani Pharmaceuticals Inc reported in an 8-K filed May 25, 2023 that Patrick D. Walsh was appointed director, effective May 23, 2023. The proxy statement of Ani Pharmaceuticals Inc reports total compensation of $962,213 for Patrick D. Walsh in fiscal 2020, including a base salary of $282,760.
“The election of eight (8) directors to serve until the Company's 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified, or until their successors shall have been duly elected and qualified”
“The election of eight (8) directors to serve until the Company’s 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified, or until their successors shall have been duly elected and qualified”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-05-22–present
-
Current
2020-05-11–present
-
2025-05-22–2020-05-10
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ani Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Nikhil Lalwani CEO, Board Member
- Thomas J. Haughey Chairman
- Stephen Carey CFO
- Muthusamy Shanmugam COO, Board Member
- Meredith W. Cook General Counsel
- Antonio Pera Board Member
- Antonio R. Pera Board Member
- David B. Nash, M.D. Board Member
- Henry Gosebruch Board Member
- Jeanne A. Thoma Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Ani Pharmaceuticals Inc (ANIP) | Former Interim President and Chief Executive Officer | $282,760 | $962,213 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.